Current research insights into the role of CTLA‐4 in hepatitis B virus (HBV) infection

Qi Gu,Shengxia Yin,Xin Tong,Fajuan Rui,Yixuan Zhu,Xiaoyan Ma,Rui Huang,Chao Wu,Jie Li
DOI: https://doi.org/10.1111/jvh.13958
2024-05-22
Journal of Viral Hepatitis
Abstract:Chronic hepatitis B virus (HBV) infection is a significant global public health concern, and the clearance of HBV is closely linked to the activity of HBV‐specific T cells, which is regulated by various co‐suppressor molecules. Cytotoxic T lymphocyte‐associated antigen 4 (CTLA‐4) is among these co‐suppressor molecules which induces T cell exhaustion by competitively inhibiting CD28 and dampening the function of HBV‐specific T cells. CTLA‐4 also plays a role in the regulation of T helper (Th) cell differentiation and influences cytokine release. In addition, CTLA‐4 can impact glucose metabolism in hepatocellular carcinoma through its interaction with T regulatory (Treg) cells. This review aims to provide a comprehensive overview of the existing literature related to the role of CTLA‐4 in HBV patients across different subsets of T cells. Additionally, we propose a discussion on the possible mechanisms through which CTLA‐4 may contribute to HBV infection, as well as the development of HBV‐induced cirrhosis and hepatocellular carcinoma.
gastroenterology & hepatology,infectious diseases,virology
What problem does this paper attempt to address?